APLT - Applied Therapeutics secures $69M via equity offering
Applied Therapeutics (APLT) has priced its 3M common shares at $23.00/share, for expected gross proceeds of $69M.Underwriters over-allotment is an additional 450K shares.Net proceeds will be used for the development of clinical and preclinical product candidates, for commercialization and other general corporate purposes. Closing date is February 17.Shares up 3% premarket.Previously (Feb. 10): Applied Therapeutics plans 3M share public offering
For further details see:
Applied Therapeutics secures $69M via equity offering